Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized Xenon Lung Imaging Atlas
NCT02112929Phase 1Completed
- Sponsor
- Oxford University Hospitals
- Start
- Apr 2012
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of xenon (129xe) in Chronic Respiratory Disease (CRD), sponsored by Oxford University Hospitals. Primary endpoint: Imaging parameters from MRI scan after inhalation of hyperpolarized xenon gas up to 1 year. Started Apr 2012; status: completed.
02
Drugs
xenon (129xe)
03
Conditions
Chronic Respiratory Disease (CRD)
Beyond the preview
Go deeper on NCT02112929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02112929.